Concepedia

Grant C. Glatfelter

GC

Statistics

Publications

20

Citations

900

H-Index

17

Active since

2020

Affiliations

National Institute on Drug Abuse(Current)

Ghent University

National Institutes of Health

University of Massachusetts Dartmouth

Medical College of Wisconsin

Grant C. Glatfelter is an author at National Institute on Drug Abuse specializing in pharmacology, medicine, and neuropharmacology.

ORCID

Publications per year

2020–2025

20

Publications

20

Virtual discovery of melatonin receptor ligands to modulate circadian rhythms

Reed M. Stein, Hye Jin Kang, John D. McCorvy et al. · Nature · 2020 · 317 citations · Full text

, , +16

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

Grant C. Glatfelter, Eline Pottie, John S. Partilla et al. · ACS Pharmacology & Translational Science · 2022 · 90 citations · Full text

, , +12

Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid

Marthe M. Vandeputte, Alex J. Krotulski, Donna Walther et al. · Archives of Toxicology · 2022 · 73 citations · Full text

, , +5

Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose

Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen et al. · Psychopharmacology · 2023 · 45 citations · Full text

, , +14

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Marthe M. Vandeputte, Nick Verougstraete, Donna Walther et al. · Archives of Toxicology · 2022 · 41 citations · Full text

, , +11

1–5 of 20